newsfilter
← Latest News
ACCESS Newswire·

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

  • Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that CFO Bill Peters & EVP Tony Marrs will present at the 2026 Bank of America Health Care Conference.
  • The presentation is scheduled for Wednesday, May 13, 2026, at 3:00 pm PT.
  • A webcast of the event will be available for 30 days via Amphastar's investor relations website at http://ir.amphastar.com.
  • Amphastar develops, manufactures, & commercializes generic & proprietary injectable, inhalation, & intranasal products, along with API products.
  • The company's finished products are distributed through group purchasing organizations, drug wholesalers, & retailers.
  • Amphastar trademarks include BAQSIMI®, Primatene MIST®, REXTOVY®, Amphadase®, & Cortrosyn®.
  • The press release includes forward-looking statements regarding future financial performance, product launches, & FDA approvals, which carry known risks & uncertainties.
  • Actual results may differ materially from projections due to factors detailed in Amphastar's SEC filings, including the 2025 Form 10-K filed on February 26, 2026.
  • Contact for media inquiries is Bill Peters at (909) 476-3416.